Home
>
Stock Market
>
>
Ajanta Pharma Ltd

Ajanta Pharma Ltd share price and stock overview

Ajanta Pharma Ltd (NSE: AJANTPHARM, BSE: 532331) operates in the Pharmaceuticals - Indian - Formulations sector. The stock has an ISIN of INE031B01049 and a face value of Rs 2. As of 24 October 2026, it trades at Rs (3,283.90) with a market capitalisation of Rs 41000.93 crore. Figures are live and subject to change.

Ajanta Pharma Ltd

Pharmaceuticals - Indian - Formulations

NSE BSE

3,283.90 13.30 (0.41%) upARrowC

As on: 24-Oct-2026 , 09:18 AM

Market Cap(₹Cr) 41000.93

Book Value(₹Cr) 337.9869392

BSE Code : 532331 NSE Symbol : AJANTPHARM EPS(TTM) : 80.61 ISIN Demat : INE031B01049 P/E(TTM) : 40.7 Face Value(₹) : 2 Div & Yield % : 0.86

Today Market

Stock Performance

Today Market

Today's High

73,766.51

Todday's Low

72,452.37

Open at

73,665.64

Previous Close

73,249.39

Volumes

Avg Price

-125.56

Historical Performance

News

15 Oct 26

Ajanta Pharma to convene a board meeting October 30 to review financial results

Ajanta Pharma Limited will hold a board meeting on Friday, October 30, 2026, to consider and approve unaudited consolidated and standalone financial results for the second quarter and half year ended September 30, 2026.

13 Oct 26

Ajanta Pharma Ltd eases for fifth straight session

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 3368.

07 Oct 26

Ajanta Pharma submitted a regulatory certificate to BSE and NSE for the September quarter

Ajanta Pharma Limited submitted a certificate to the BSE Limited and National Stock Exchange of India under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by MUFG Intime India Private Limited, formerly Link Intime India Private Limited, the company’s registrar and share transfer agent.

06 Oct 26

Aayush Agrawal pledged Ajanta Pharma shares to secure non-convertible debentures issuance

Aayush Agrawal, trustee of Aayush Agrawal Trust, disclosed the creation of a pledge on 4,60,000 equity shares of Ajanta Pharma Limited on September 28, 2026, for the purpose of issuing non-convertible debentures.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
23-10-26	3261.40	3349.60	3224.30	3283.90	154847	25399	509345052.50	22600.00
22-10-26	3215.10	3291.20	3199.90	3270.60	58123	15438	189001853.10	22687.65
21-10-26	3285.00	3314.30	3250.00	3260.20	53439	16469	174388418.10	22811.35
19-10-26	3325.90	3387.50	3285.00	3298.90	36644	10921	121865840.40	22888.95
16-10-26	3372.50	3381.00	3308.30	3329.00	38358	12363	128308771.80	23146.15
15-10-26	3330.00	3387.70	3313.70	3359.40	103485	17402	347201503.00	22997.35
14-10-26	3328.20	3377.20	3269.90	3299.00	74868	17513	248159314.40	22622.70
13-10-26	3399.40	3413.90	3310.00	3328.20	52616	6806	176276464.70	22721.95
12-10-26	3405.00	3421.40	3380.90	3399.40	92290	17338	313802361.00	22363.35
09-10-26	3437.90	3478.20	3364.40	3410.10	124419	29374	423899494.10	22520.45

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

41000.93

PE Ratio

40.7

PB Ratio

9.71

Dividend Yield

0.86

ROE

24.13

ROCE

30.64

Book Value (₹)

337.9869392

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

0.00

Indian

Bodies Corporate-Indian (Promoter & Group)	12588393	10.07	12588393	1
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	66725384	53.40	66725384	7
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	0	0.00	0	0
Others	0	0.00	0	0

Sub Total

79313777

63.47

79313777

Total ShareHolding for Promoter & Group

79313777

63.47

79313777

Publice Share Holding

Institution

Government(Central / State)	0	0.00	0	0
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	55	0.00	55	1
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	9530731	7.63	9530731	273
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	4477877	3.58	4477877	19
Mutual Funds / UTI	22425500	17.95	22425500	34
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	517533	0.41	517533	26
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

36951696

29.57

36951696

353

Non Institution

Bodies Corporate	226988	0.18	226613	527
Clearing Members	16978	0.01	16978	25
Directors & their Relatives	0	0.00	0	0
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	361705	0.29	361705	2402
Foreign Non Institution Other	0	0.00	0	0
Hindu Undivided Families	161330	0.13	161330	1075
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	794098	0.64	794098	5
Individuals holding nominal share capital up to Rs. 1 lakh	6959786	5.57	6831909	57462
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	1272	0.00	1272	4
Others	137996	0.11	137996	3

Sub Total

8693551

6.96

8565299

61562

Total Public Shareholding

45645247

36.53

45516995

61915

Total of Promoter & Public ShareHolding

124959024

100.00

124830772

61923

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	0	0.00	0	0

Total Shares held by Custodians and against which Depository Receipts have been issued

0.00

Grand Total

124959024

100.00

124830772

61923

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Net Sales	5,452.86	4,648.10	4,208.71	3,742.64	3,340.99
OPM (%)	25.26	25.58	26.47	19.91	27.22
OP	1,377.65	1,189.16	1,113.93	745.25	909.48
Other Income	172.07	94.50	84.60	98.64	115.68
PBIDT	1,566.90	1,354.00	1,256.54	881.89	1,044.98
INTEREST	16.11	20.73	7.21	5.84	10.20
PBDT	1,550.79	1,333.27	1,249.33	876.05	1,034.78
PBT	1,377.65	1,189.16	1,113.93	745.25	909.48
EO	0.00	0.00	0.00	0.00	0.00
PBT after EO	1,377.65	1,189.16	1,113.93	745.25	909.48
TAXES	321.65	268.77	297.76	157.27	196.80
PAT	1,056.00	920.39	816.17	587.98	712.68
EPS	84.51	73.53	61.77	45.89	54.96
Raw Material	16.81	18.21	22.32	23.47	23.33
Power and Fuel	1.34	1.51	1.58	1.76	1.63
Employee Cost	23.68	23.44	21.39	20.98	19.33
Other Manufacturing Expenses	0.00	0.00	0.00	0.00	0.00
Selling and Administration Expenses	19.85	18.56	17.78	20.97	19.54
Miscellaneous Expenses	3.74	2.07	2.06	2.34	1.68
Revenue (Growth %)	17.31	10.44	12.45	12.02	15.62
PBIDT (Growth %)	15.72	7.76	42.48	-15.61	2.00
PAT (Growth %)	14.73	12.77	38.81	-17.50	8.99
PBIDT (Margin %)	28.74	29.13	29.86	23.56	31.28
PAT (Margin %)	19.37	19.80	19.39	15.71	21.33

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	25.07	25.07	25.27	25.27	17.17	17.39
Reserves Total	4198.46	3600.24	3388.30	3221.18	3152.01	2867.59
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	4223.53	3625.31	3413.57	3246.45	3169.18	2884.98
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	34.69	31.17	30.52	32.90	20.49	25.91
Total Debt	34.69	31.17	30.52	32.90	20.49	25.91
Other Liabilities	54.64	83.32	43.25	27.83	23.41	22.52
Total Liabilities	4312.86	3739.80	3487.34	3307.18	3213.08	2933.41
APPLICATION OF FUNDS :
Gross Block	2996.35	2759.58	2355.33	2246.28	2163.18	2086.54
Less : Accumulated Depreciation	1151.58	1017.62	890.44	762.27	670.86	567.75
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1844.77	1741.96	1464.89	1484.01	1492.32	1518.79
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	258.05	176.27	256.45	209.47	152.86	108.19
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	606.24	481.84	367.14	553.26	164.85	156.88
Current Assets, Loans & Advances
Inventories	844.71	739.29	677.79	683.77	635.11	634.22
Sundry Debtors	1365.77	1225.81	1207.67	977.63	1043.62	782.30
Cash and Bank Balance	90.55	49.72	63.06	269.92	145.25	151.98
Loans and Advances	257.78	122.53	163.10	109.60	111.17	128.72
Total Current Assets	2558.81	2137.35	2111.62	2040.92	1935.15	1697.22
Less : Current Liabilities and Provisions
Current Liabilities	850.04	663.96	566.54	874.39	446.80	459.91
Provisions	35.88	39.98	55.06	25.50	18.74	46.57
Total Current Liabilities & Provisions	885.92	703.94	621.60	899.89	465.54	506.48
Net Current Assets	1672.89	1433.41	1490.02	1141.03	1469.61	1190.74
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	39.99	37.25	35.00	34.30	28.15	0.00
Deferred Tax Liability	157.93	147.76	143.50	132.02	130.02	92.17
Net Deferred Tax	-117.94	-110.51	-108.50	-97.72	-101.87	-92.17
Other Assets	48.85	16.83	17.34	17.13	35.31	50.98
Total Assets	4312.86	3739.80	3487.34	3307.18	3213.08	2933.41
Contingent Liabilities	8.12	8.12	4.94	4.55	7.28	82.90

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	-457.30	-105.12	-1,047.70	-715.71	-359.62
Investing Activities	-66.04	-501.31	105.02	-349.60	-399.56
Net Cash Flow	19.00	129.86	-207.33	-11.51	44.65
Operating Activities	542.34	736.29	735.35	1,053.80	803.83

Peers

Balance Sheet Financial Ratios Profit & Loss

Accretion Nutrav...

Adline Chem Lab ...

Amrutanjan Healt...

487.65

(-1.88%)

Bafna Pharmaceut...

442.95

(-1.99%)

BDH Industries L...

Bharat Immunolog...

Bharat Parentera...

1,690.00

(-4.84%)

Bio Medica Labor...

149.75

(-3.39%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer

MBA

Mannalal B Agrawal

Chairman & Non Executive Dir.

Executive

MBA

Madhusudan B Agrawal

Vice Chairman & Executive Dire

Executive

Independent Directors

David Rasquinha

Independent Non Exe. Director

Ind.

RSD

Rajesh Shashikant Dalal

Independent Non Exe. Director

Ind.

Medha Joshi

Independent Non Exe. Director

Ind.

Simi Thapar

Independent Non Exe. Director

Ind.

Other Officials

Yogesh Agrawal

ED / MD / Promoter

Board

RMA

Rajesh M Agrawal

ED / WTD / Joint MD / Promoter

Board

Gaurang Shah

Senior Vice President & CS

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Ajanta Pharma Ltd? −

Ajanta Pharma Ltd trades on NSE under AJANTPHARM and on BSE under code 532331. The ISIN is INE031B01049 and the face value is Rs 2.

What is the share price of Ajanta Pharma Ltd today? +

As of 24 October 2026, Ajanta Pharma Ltd trades at Rs 3,283.90, a change of 13.30 (0.41%) on the day. Prices are live and subject to change.

What is the market capitalisation of Ajanta Pharma Ltd? +

As of 24 October 2026, Ajanta Pharma Ltd has a market cap of about Rs 41000.93 crore. This figure is live and moves with the share price.

Is Ajanta Pharma Ltd profitable? +

In March 2026, Ajanta Pharma Ltd reported a profit after tax of Rs 1,056.00 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Ajanta Pharma Ltd? +

: As of 24 October 2026, the PE (TTM) for Ajanta Pharma Ltd is 40.7 and the price-to-book ratio is 9.71. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Ajanta Pharma Ltd pay a dividend? +

As of 24 October 2026, the dividend yield for Ajanta Pharma Ltd is 0.86%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Ajanta Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 63.47% of Ajanta Pharma Ltd. Public shareholding is 36.53%, including mutual funds at 17.95% and foreign institutional investors at 7.63%.

What were the latest annual financials of Ajanta Pharma Ltd? +

In March 2026, Ajanta Pharma Ltd reported net sales of Rs 5,452.86 crore, revenue growth of 17.31%, and earnings per share of Rs 84.51.